Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 166

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 166
---
 the committee.

The quorum required for the
convening of meetings of the audit committee and for adopting resolutions by the audit committee is a majority of the members of the audit
committee, provided such majority is comprised of a majority of independent directors, at least one of whom is an external director.

Approval of transactions with related parties

Under the Companies Law, the
approval of the audit committee is required to effect specified actions and transactions with office holders and controlling shareholders
and their relatives, or in which they have a personal interest. See “Management—Fiduciary duties and approval of specified
related party transactions under Israeli law.” The audit committee may not approve an action or a transaction with a controlling
shareholder or with an office holder unless at the time of approval the audit committee meets the composition requirements under the Companies
Law.

Audit committee role

Our board of directors has
adopted an audit committee charter, which will be effective as of the effective time of the registration statement to which this prospectus
relates setting forth the responsibilities of the audit committee consistent with the rules of the SEC and the Nasdaq Marketplace Rules,
which include, among others:

| ● | retaining and terminating our independent auditors, subject to the ratification of the board of directors, and in the case of retention, to that of the shareholders; |

| ● | pre-approving of audit and non-audit services and related fees and terms, to be provided by the independent auditors; |

| ● | overseeing the accounting and financial reporting processes of the Company and audits of our financial statements, the effectiveness of our internal control over financial reporting and making such reports as may be required of an audit committee under the rules and regulations promulgated under the Exchange Act; |

<div align='center'>101</div>

| ● | reviewing with management and our independent auditor our annual and quarterly financial statements prior to publication or filing (or submission, as the case may be) to the SEC; |

| ● | recommending to the board of directors the retention and termination of the internal auditor, and the internal auditor’s engagement fees and terms, in accordance with the Companies Law as well as approving the yearly or periodic work plan proposed by the internal auditor; |

| ● | reviewing with our general counsel and/or external counsel, as deem necessary, legal and regulatory matters that could have a material impact on the financial statements; |

| ● | identifying irregularities in our business administration, inter alia, by consulting with the internal auditor or with the independent auditor